Skip to main content

FDA enforcement comparison

Philips North America vs The Harvard Drug Group LLC: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 3 for The Harvard Drug Group LLC.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

The Harvard Drug Group LLC: 0 warning letters, 3 recalls, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0
The Harvard Drug Group LLC — Warning letters0
Philips North America — Recalls355
The Harvard Drug Group LLC — Recalls3
Philips North America — Approval records0
The Harvard Drug Group LLC — Approval records0
Philips North America — Form 483s0
The Harvard Drug Group LLC — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

The Harvard Drug Group LLC

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs The Harvard Drug Group LLC: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-the-harvard-drug-group-llc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗